fda drug shortage tirzepatide says that the GLP-1 is over The FDA says the Zepbound

Autonomic and neurological features: Patients may notice sweating, palpitations, tremor, or a sensation of weakness alongside faintness

In addition, the HA/ZIF-8@Gem/D-1-MT nanoparticles obtained by loading gemcitabine and D-1-methyltryptophan into ZIF-8 and then modifying with HA, can also reactivate anti-tumor immunity by inhibiting indoleamine 2,3-dioxygenase and reducing the infiltration of M-MDSCs and G-MDSCs (123)

The key is working with your provider to find your personal maintenance threshold rather than assuming you must stop entirely

Appetite Regulation and Satiety Beyond simply promoting weight loss, GLP-1 receptor agonists help regulate appetite and increase feelings of fullness (satiety)